Featured Research

from universities, journals, and other organizations

Topical Application Of A Protein Heals Wounds

Date:
October 2, 2000
Source:
NIH-National Institute Of Dental And Craniofacial Research
Summary:
Scientists have discovered that a multipurpose protein found in several bodily fluids has another important function--it can promote the healing of abnormal skin wounds, which are a significant problem in the elderly.

Scientists have discovered that a multipurpose protein found in several bodily fluids has another important function--it can promote the healing of abnormal skin wounds, which are a significant problem in the elderly.

Related Articles


Working with a new animal model for delayed wound healing that they produced, researchers at the National Institute of Dental and Craniofacial Research (NIDCR) demonstrated that the protein, called secretory leukocyte protease inhibitor, or SLPI (pronounced slippy), plays a critical role in normal wound healing. When SLPI was applied topically to non-healing wounds, it actually reversed tissue destruction and hastened healing.

Each year, more than four million older people suffer from chronic, non-healing wounds such as diabetic ulcers, bedsores, and venous ulcers. Inflammation and bacterial infection are two of the major problems that often contribute to delayed healing. Even acute wounds sometimes fail to heal properly in the elderly. Not only are non-healing wounds painful, but they are expensive to treat. The cost of wound care is over $3 billion annually.

Previous laboratory studies have suggested that SLPI is involved in the wound healing process. The protein, which is also found in fluids that bathe mucosal surfaces such as bronchial fluids, cervical fluids, and saliva, is a remarkably versatile substance. It has anti-inflammatory, anti-viral, anti-fungal, and anti-bacterial properties. In recent years, NIDCR investigators demonstrated that SLPI found in saliva blocks HIV-1 infection.

Reporting in the October issue of Nature Medicine, the scientists described their development of a new animal model that mimics the major components of non-healing wounds. These SLPI knockout mice--mice that lack the SLPI gene--showed markedly impaired skin wound healing with an increase in inflammation and the activity of the enzyme elastase, which destroys tissue. The researchers demonstrated that without the presence of SLPI to act as a molecular brake, a cascade of events occurs that results in the destruction of tissue and impaired wound healing. But topical application of SLPI actually reverses the abnormal response and enhances the rate of healing.

The researchers believe that SLPI has three major functions in wound healing. It inhibits elastase, controls the activation of leukocytes, and reduces TGF-Beta; activation. When a wound occurs, a wide variety of structural and functional proteins such as proteoglycans, collagen and fibronectin are marshaled to the wound site. Unchecked by SLPI, elastase will degrade these proteins, causing a breakdown in the tissue matrix. Furthermore, SLPI controls the activation of leukocytes. Inflammatory cells are attracted to a wound by multiple stimuli, including the protein TGF-Beta; (transforming growth factor beta), which is produced in wounds and controls cellular proliferation and differentiation. In the absence of SLPI, TGF-Beta; goes into overdrive and exacerbates inflammation.

"SLPI appears to be a component of innate or natural host defense that maintains a balance between protective inflammatory responses and overzealous or uncontrolled inflammation that can lead to tissue destruction and failure to heal," explained Dr. Sharon Wahl, principal investigator on the study and chief of NIDCR's Oral Infection and Immunity Branch.

Interestingly, the researchers note that the fact that animals tend to lick their wounds may be nature's way of delivering SLPI to the wound site via saliva.

Plans are underway for a clinical trial to test SLPI as a treatment for delayed healing of skin wounds in the elderly. The researchers also suggest that findings from their current study may be extended to other conditions that involve excessive elastase activity, such as gingivitis and bullous pemphigoid.

Collaborating with Dr. Wahl on the study were Drs. Gillian S. Ashcroft, Ke-jian Lei, Wenwen Jin, Teresa Greenwell-Wild, Hollie Hale-Donze, George McGrady, and Xiao-Yu Song from the NIDCR Oral Infection and Immunity Branch, and Drs. Glenn Longnecker and Ashok B. Kulkarni from the NIDCR Gene Targeting Facility. The National Institute of Dental and Craniofacial Research is one of the federal National Institutes of Health, located in Bethesda, MD.


Story Source:

The above story is based on materials provided by NIH-National Institute Of Dental And Craniofacial Research. Note: Materials may be edited for content and length.


Cite This Page:

NIH-National Institute Of Dental And Craniofacial Research. "Topical Application Of A Protein Heals Wounds." ScienceDaily. ScienceDaily, 2 October 2000. <www.sciencedaily.com/releases/2000/10/001002071718.htm>.
NIH-National Institute Of Dental And Craniofacial Research. (2000, October 2). Topical Application Of A Protein Heals Wounds. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2000/10/001002071718.htm
NIH-National Institute Of Dental And Craniofacial Research. "Topical Application Of A Protein Heals Wounds." ScienceDaily. www.sciencedaily.com/releases/2000/10/001002071718.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins